Overview
Issue date: 14th April 2025 (Version 6). Please ensure you are reading the most up to date version.
The most up to date advice about the ongoing Creon, Nutrizym and Pancrex supply issues can be found on the Pancreatic Society of Great Britain and Ireland (PSGBI) website: https://www.psgbi.org/position-statement-pert-shortage/. If you would like a printed copy, you can e-mail us at info@gutscharity.org.uk or call us on 0207 486 0341.
Manufacturers have customer support lines that may help you find a pharmacist nearby with stock.
- Creon: 0800 8086410 (Monday-Friday, 9am-5pm)
- Nutrizym: 08000 902408 (Monday-Friday, 9am-5pm)
Advice for children and those with cystic fibrosis (CF)
Please note, the advice in this document is designed for adults with PEI. Specialist advice should be sought for children with PEI. People with cystic fibrosis (CF) will be cared for by a specialist centre. We have highlighted that some of the advice in this leaflet is not for people with CF. If you have CF, you should contact your specialist team if you have any concerns.
Advice for those with (non-pancreatic) neuroendocrine neoplasms treated with somatostatin analogues
Somatostatin analogues are the medicines Lanreotide (Somatuline®)/Octreotide (Sandostatin®). Please contact your specialist centre if your symptoms worsen, or you have any concerns.

Introduction
Please note. this information has been extensively revised in view of the availability of imported alternatives to Creon®, Nutrizym® and Pancrex®. Everyone should now be able to get the enzymes they need but they might be a different brand.
Doctors prescribe pancreatic enzyme replacement therapy to support adequate digestion in people with pancreatic exocrine insufficiency (PEI). Most commonly PEI is caused by pancreatic cancer, pancreatitis, pancreatic surgery, neuroendocrine cancers and cystic fibrosis (CF).
Many other clinical situations can cause primary or secondary PEI. These include:
- Gastrectomy (stomach removal surgery) or gastric bypass surgery.
- People who take the medicine somatostatin analogues [Lanreotide (Somatuline®) / Octreotide (Sandostatin®)] for the treatment of neuroendocrine neoplasms (NENs).
PEI has many causes, but symptoms and their severity vary from person to person.
The ongoing supply issues surrounding pancreatic enzyme replacement therapy (PERT) is going to continue until the end of 2026.
PERT are supplied under the product brands: Creon®, Nutrizym® and Pancrex®. These supply issues are intermittent. The current supply issues mean some people will need to be supplied with a different brand of PERT. This advice is designed for everyone who takes PERT.

Current supplies
- Creon® 25,000 is being delivered regularly into the UK, but at 90-95% of the usual stock levels. Up to 1 in 10 prescriptions will not be filled with their usual brand.
- Creon® 10,000 is available in limited supplies and should be prioritised for babies/infants and those unable who cannot swallow capsules and are unable to open them.
- Nutrizym 22® is available in limited supplies and should be prioritised for those who cannot tolerate Creon.
- Pancrex® capsules are available, but there is not any extra supply. So they cannot fill the gap in the market. These products are low dose and so most adults would need to take a lot of them to get what they need.
- Pancrex® powder is not usually suitable for taking by mouth. If you are provided with a prescription for this and you take it by mouth do not collect it from the pharmacy. Once it has been collected, it cannot be reused. This product is used by people who have a feeding tube. Let your doctor or pharmacist know you will need an alternative.
- GP’s and pharmacies have been provided with information on ordering imported medicines to meet the gap in the supply. These should be ordered for anyone who may run out of PERT.
For the most up to date information on current supplies please check the Specialist Pharmacy Service website: Prescribing and ordering available pancreatic enzyme replacement therapies – SPS – Specialist Pharmacy Service – The first stop for professional medicines advice. This website also has a tool to help healthcare professionals to change the type of PERT. Please contact us if you would like a copy on info@gutscharity.org.uk or call 020 7486 0341.
Symptoms of untreated PEI may include:
- Crampy belly (abdominal) pain
- Steatorrhea (pale floating stools)
- Hard to manage blood glucose levels
- Vitamin and mineral deficiencies
- Weight loss and malnutrition
These symptoms are usually treated by taking PERT and will recur if you are unable to take enough.
We have divided the advice for people with PEI into three stages. The stage depends on the supply available:
- Stage 1: What to do when you have a supply.
- Stage 2: What to do if you think you need to increase your dose.
- Stage 3: What to do if you have less than two weeks supply left.